[go: up one dir, main page]

DK140393D0 - Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et laegemiddel mod en adenovirusinfektion, farmaceutisk praeparater indeholdende forbindelsen samt fremgangsmaade til fremstilling af forbindelsen - Google Patents

Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et laegemiddel mod en adenovirusinfektion, farmaceutisk praeparater indeholdende forbindelsen samt fremgangsmaade til fremstilling af forbindelsen

Info

Publication number
DK140393D0
DK140393D0 DK931403A DK140393A DK140393D0 DK 140393 D0 DK140393 D0 DK 140393D0 DK 931403 A DK931403 A DK 931403A DK 140393 A DK140393 A DK 140393A DK 140393 D0 DK140393 D0 DK 140393D0
Authority
DK
Denmark
Prior art keywords
compound
adenovirus infection
nicleoside
iodated
uracil
Prior art date
Application number
DK931403A
Other languages
English (en)
Other versions
DK140393A (da
Inventor
John William Talbot Selway
Iii Lowrie Miller Beacham
Susan Mary Daluge
Joel Van Tuttle
Thomas Anthony Krenistky
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK140393D0 publication Critical patent/DK140393D0/da
Publication of DK140393A publication Critical patent/DK140393A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK140393A 1987-08-22 1993-12-17 Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutisk præparater indeholdende forbindelsen samt fremgangsmåde til fremstilling af forbindelsen DK140393A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878719877A GB8719877D0 (en) 1987-08-22 1987-08-22 Antiviral compounds

Publications (2)

Publication Number Publication Date
DK140393D0 true DK140393D0 (da) 1993-12-17
DK140393A DK140393A (da) 1993-12-17

Family

ID=10622673

Family Applications (3)

Application Number Title Priority Date Filing Date
DK468288A DK169657B1 (da) 1987-08-22 1988-08-19 Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider
DK091692A DK169437B1 (da) 1987-08-22 1992-07-14 Chloreret uracilnucleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutiske præparater indeholdende forbindelsen samt fremgangsmåde ti l fremstilling af forbindelsen
DK140393A DK140393A (da) 1987-08-22 1993-12-17 Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutisk præparater indeholdende forbindelsen samt fremgangsmåde til fremstilling af forbindelsen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK468288A DK169657B1 (da) 1987-08-22 1988-08-19 Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider
DK091692A DK169437B1 (da) 1987-08-22 1992-07-14 Chloreret uracilnucleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutiske præparater indeholdende forbindelsen samt fremgangsmåde ti l fremstilling af forbindelsen

Country Status (19)

Country Link
US (2) US5070078A (da)
EP (2) EP0479336A1 (da)
JP (1) JP2634202B2 (da)
KR (1) KR890003382A (da)
AT (1) ATE82681T1 (da)
AU (1) AU613659B2 (da)
CA (1) CA1333361C (da)
DE (1) DE3876174T2 (da)
DK (3) DK169657B1 (da)
ES (1) ES2052732T3 (da)
GB (1) GB8719877D0 (da)
GR (1) GR3006510T3 (da)
HU (1) HU211666A9 (da)
IE (2) IE63655B1 (da)
MX (1) MX9203416A (da)
NZ (1) NZ225881A (da)
PT (1) PT88306B (da)
SG (1) SG26364G (da)
ZA (1) ZA886182B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application
GB9003543D0 (en) * 1990-02-16 1990-04-11 Wellcome Found Therapeutic nucleosides
US5166327A (en) * 1990-07-31 1992-11-24 Yuki Gosei Kogyo Co., Ltd. Process for producing 3'-deoxy-3-'-fluorothymidine
JP2804184B2 (ja) * 1991-05-14 1998-09-24 シャープ株式会社 ファクシミリ装置
DE4121001C1 (da) * 1991-06-21 1993-05-06 Max-Delbrueck-Centrum Fuer Molekulare Medizin Berlin-Buch, O-1115 Berlin, De
US5341595A (en) * 1992-06-15 1994-08-30 Environmental Growth Chambers Environmental chamber for plant growth analysis
GB9309787D0 (en) * 1993-05-12 1993-06-23 Rhone Poulenc Chemicals Purification of fluoronucleosides
ATE169027T1 (de) * 1993-05-12 1998-08-15 Rhodia Limited Herstellung von fluoro-nukleosiden und dafür geeignete zwischenprodukte
SE503787C2 (sv) * 1994-12-07 1996-09-02 Electrolux Ab Anordning för att tillhandahålla kylda eller frysta varor
US5690202A (en) * 1996-04-15 1997-11-25 Myers; John E. Overrunning clutch mechanism
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6855561B2 (en) * 2001-09-10 2005-02-15 Quidel Corporation Method for adding an apparent non-signal line to a lateral flow assay
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
WO2004002433A1 (en) * 2002-06-27 2004-01-08 Medivir Ab Synergistic interaction of abacavir and alovudine
CN1248266C (zh) * 2002-12-26 2006-03-29 邱智铭 一种转动式电开关结构
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
RU2628456C1 (ru) * 2016-06-29 2017-08-17 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Новые пиримидиновые ингибиторы репликации аденовируса человека

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE103241C (da) *
GB1251828A (da) * 1968-12-19 1971-11-03
DE1913384C2 (de) * 1968-12-20 1982-12-16 Akademie Der Wissenschaften Der Ddr, Ddr 1199 Berlin 1-(2',3'-Didesoxy-3'-fluor-β-D-xylofuranosyl)-thymin, Verfahren zu seiner Herstellung und dieses enthaltende Cytostatica
GB1189973A (en) * 1969-02-14 1970-04-29 Akad Wissenschaften Ddr Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
DD103241A1 (da) * 1972-12-12 1974-01-12
EP0265431A1 (de) * 1985-07-23 1988-05-04 WOLF, Karl Schaltungsanordnung zum starten und zum betrieb mindestens einer niederdruck- oder hochdruck-gasentladungslampe mit hochfrequenten schwingungen
DK167377B1 (da) * 1985-09-17 1993-10-25 Wellcome Found 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application

Also Published As

Publication number Publication date
EP0479336A1 (en) 1992-04-08
IE63655B1 (en) 1995-05-31
DK91692D0 (da) 1992-07-14
DE3876174D1 (de) 1993-01-07
DK468288A (da) 1989-02-23
DK468288D0 (da) 1988-08-19
HU211666A9 (en) 1995-12-28
EP0305117A3 (en) 1989-12-27
KR890003382A (ko) 1989-04-14
MX9203416A (es) 1992-07-01
DE3876174T2 (de) 1993-04-01
PT88306A (pt) 1989-06-30
CA1333361C (en) 1994-12-06
IE940696L (en) 1989-02-22
US5070078A (en) 1991-12-03
JP2634202B2 (ja) 1997-07-23
EP0305117A2 (en) 1989-03-01
JPS6468325A (en) 1989-03-14
ATE82681T1 (de) 1992-12-15
DK169437B1 (da) 1994-10-31
PT88306B (pt) 1995-12-29
SG26364G (en) 1995-09-18
EP0305117B1 (en) 1992-11-25
ES2052732T3 (es) 1994-07-16
DK140393A (da) 1993-12-17
GR3006510T3 (da) 1993-06-30
AU613659B2 (en) 1991-08-08
ZA886182B (en) 1990-04-25
DK91692A (da) 1992-07-14
AU2142988A (en) 1989-05-25
IE882533L (en) 1989-02-22
US5376644A (en) 1994-12-27
GB8719877D0 (en) 1987-09-30
NZ225881A (en) 1991-03-26
DK169657B1 (da) 1995-01-09

Similar Documents

Publication Publication Date Title
DK140393D0 (da) Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et laegemiddel mod en adenovirusinfektion, farmaceutisk praeparater indeholdende forbindelsen samt fremgangsmaade til fremstilling af forbindelsen
SE8804629D0 (sv) New therapeutically active compounds
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
MX9203808A (es) Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
DK253988D0 (da) Farmaceutisk praeparat med indhold af eperison eller tolperison, eller et salt deraf, til indgivelse gennem huden
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO883047L (no) Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytiske tilberedninger inneholdende dem ogderes anvendelse.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK623888D0 (da) 9a-allyl- og propargylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antibakterielle laegemidler
SE8704049D0 (sv) Novel pharmacological compounds
IT7922269A0 (it) Preparati di corticosteroidi per somministrazione orale.
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it
IT8721157A0 (it) Composto terapeuticamente utile, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment
PUP Patent expired